Recurrence Risk Stratification in Clear Cell Renal Cell Carcinoma Using TNM 2017 and WHO/ISUP Grade
Anticancer Research · 2026
DOI: 10.21873/anticanres.18154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Kosuke Hamada und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Recurrence, Local.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
- Department of Urology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan; tysy-y@mx5.canvas.ne.jp.
- Department of Pathology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
- Department of Surgical Pathology, Hyogo Medical University, Hyogo, Japan.
Zitieren
APA
Hamada, K., Yamasaki, T., Ohe, C., Tsujio, N., Yamamoto, S., Matsue, T., Yukimatsu, N., Otoshi, T., Kato, M., Kuratsukuri, K., Shiohara, M., Kohashi, K., & Uchida, J. (2026). Recurrence Risk Stratification in Clear Cell Renal Cell Carcinoma Using TNM 2017 and WHO/ISUP Grade. Anticancer Research. https://doi.org/10.21873/anticanres.18154
Vancouver
Hamada K, Yamasaki T, Ohe C, Tsujio N, Yamamoto S, Matsue T, et al. Recurrence Risk Stratification in Clear Cell Renal Cell Carcinoma Using TNM 2017 and WHO/ISUP Grade. Anticancer Research. 2026. doi:10.21873/anticanres.18154
BibTeX
@article{Hamada2026,
author = {Hamada, Kosuke and Yamasaki, Takeshi and Ohe, Chisato and Tsujio, Nozomi and Yamamoto, Shoma and Matsue, Taisuke and Yukimatsu, Nao and Otoshi, Taiyo and Kato, Minoru and Kuratsukuri, Katsuyuki and Shiohara, Masanori and Kohashi, Kenichi and Uchida, Junji},
title = {Recurrence Risk Stratification in Clear Cell Renal Cell Carcinoma Using TNM 2017 and WHO/ISUP Grade},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18154}
}
EUVIMED